CBZ

Conclusions

• 🟢Price vs. SMA 50 — Price is above the 50-day average
• 🟢Price vs. SMA 200 — Price is above the 200-day average
• 🟢MACD — MACD histogram is positive — rising momentum
• 🔴RSI — RSI 81.2 — approaching overbought territory
• 🔴Stochastic — %K 93.3 — overbought
• 🟢ADX (trend strength) — ADX 42.8 — strong trend
• 🟢Relative strength vs. S&P 500 — +78.9% over the last 3 months relative to the index
• 🟢Bollinger Bands — Price is in the upper third of the Bollinger Bands (81%B) — strong momentum (risk of a pullback)
• 🟢ROC (rate of change) — ROC 12 days: 33.1%
• 🟢Parabolic SAR — Price is above the SAR point — uptrend
• 🟢CMF (money flow) — CMF 20 days: 0.22

3️⃣ Suggested Exit Point (ATR-based)

Method formula: Stop-loss = support minusone ATR margin — this way the stop adapts to the stock's actual volatility, rather than an arbitrary number.

Profit Targets by Risk/Reward Ratio (R)

Conclusions

• 🔴Gross margin — Gross margin: 12.9% — weak
• 🔴Operating margin — Operating margin: 8.5% — weak
• 🔴Net margin — Net margin: 4.2% — weak
• 🔴Return on equity (ROE) — Return on equity (ROE): 6.6% — weak
• 🔴Return on assets (ROA) — Return on assets (ROA): 2.6% — weak
• 🟡Current ratio (liquidity) — Current ratio: 1.22
• 🟡Debt-to-equity — Debt/equity: 0.83
• 🟡Interest coverage — Interest coverage: 2.2x

Conclusions

• 🟢Revenue growth (last year) — Revenue growth (last year): 52.1%
• 🟢Earnings per share (EPS) growth — Earnings per share (EPS) growth: 134.6%
• 🟢Free cash flow growth — Free cash flow growth: 58.4%
• 🟢Net income growth — Net income growth: 181.3%

Conclusions

• 🔴DCF Fair Value — Estimated fair value: $48.09 vs. price $54.49 (-11.7%)
• 🟡Tangible Net Asset Value (NAV) — NAV per share: -$8.98
• 🟡P/E — P/E: 29.8